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ABSTRACT   
Supercritical extracts of marigold (ME) were produced and characterized. The bioaccessibility of 1 
terpenes, especially that of pentacyclic triterpenes (PT), the particle-size distribution and 2 
antioxidant activity after the in vitro co-digestion of ME with olive oil (OO), were determined. ME 3 
produced without co-solvent was richer in taraxasterol, lupeol, α-amyrin and β-amyrin than extracts 4 
with co-solvent. All terpenes showed high bioaccessibility without OO (>75%). Significant 5 
correlations were found between the molecular properties of compounds (logP and number of 6 
rotatable bonds) and their bioaccessibility. Co-digestion with OO enhanced the bioaccessibility 7 
(around 100% for PT), which could be related to a higher abundance of low-size particles of the 8 
digestion medium. The antioxidant activity of the digested ME increased around 50%, regardless of 9 
OO. PT-rich extracts from marigold display high bioaccessibility and improved antioxidant activity 10 
after in vitro digestion, although complete bioaccessibility of PT can be reached by co-digestion 11 
with oil, without affecting antioxidant activity. 12 
 13 
Keywords: Calendula officinalis, pentacyclic triterpenes, bioaccessibility, lipid digestion, excipient 14 
foods 15 
16 
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INTRODUCTION 17 
Calendula officinalis L. (common name marigold) belongs to the order of Asterales and is a 18 
member of the family Asteraceae. This herbaceous plant, native of the Mediterranean climate areas, 19 
is traditionally cultivated in several countries for ornamental, medical and cosmetic purposes.  20 
Although it is not extensively known, some edible uses have been described for flowers and leaves. 21 
The fresh petals can be chopped and added to salads, curry or custard. The dried petals have a more 22 
intense flavor and are used as seasoning in soups, cakes, drinks and baked products. A tea can be 23 
prepared from the flowers and petals, and the leaves can be also eaten raw in salads.1–3 24 
The traditional medicinal use of the marigold is related to its great variety of phytochemicals of 25 
bioactive interest, such as terpenoids, sterols, saponins, carotenoids and phenolic compounds, 26 
mainly in flower extracts. Due to this complex composition, the extracts of marigold have been 27 
related to activities such as antioxidant, antiinflammatory, immunostimulant, anticancer, 28 
hepatoprotective, antimicrobial and wound healing.1–4 The triterpenoids as pentacyclic triterpenes 29 
(PT) have been described as one of the main responsible for the biological activities of marigold, 30 
especially as anti-inflammatory.4 The typical PT of the marigold are monohydroxy alcohols (α-31 
amyrin, β-amyrin, taraxasterol and lupeol), and dihydroxyalcohols (faradiol, arnidiol, brein or 32 
calenduladiol).  33 
Taking into account the biological interest of all these compounds, the production of extracts of 34 
marigold rich in these bioactive compounds is of current interest. Within the most popular methods 35 
for production of plant extracts, the green technology of supercritical fluid extraction (SFE) is quite 36 
popular nowadays, with special use in the extraction of compounds with low polarity that are 37 
soluble in supercritical CO2, such as the PT. The supercritical CO2 extraction assisted by co-solvents 38 
such as ethanol may also enhance the yield of extraction. In the specific case of marigold, diverse 39 
studies have reported the use of SFE,5–7 but the use of co-solvents has been scarcely explored.7 40 
Furthermore, many of them have been focused in the extraction and characterization of the essential 41 
oil rich in sesquiterpenes,8–10 although the content in PT is not always reported. 42 
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It is important to remark that most of the described bioactive compounds of marigold are 43 
compounds of a typical low polarity and high hydrophobicity, which leads to a limitation in their 44 
potential use and bioactivity. However, it seems that the available information on the behavior of 45 
PT during the gastrointestinal process, bioaccessibility and bioavalability is still scarce and 46 
contradictory. It has been suggested that the bioavailability of PT is poor due to a difficult 47 
solubilization in the aqueous media of the gastrointestinal tract, necessary for a proper absorption.11 48 
However, other studies reported that some PT of fruits and plants were effectively absorbed and 49 
deposited in their intact forms in diverse tissues in mice.12 In the specific case of the typical PT of 50 
marigold, some studies have described that lupeol is bioavailable,13 whereas other studies have 51 
suggested the opposite.14,15 Ching, Lin, Tan & Koh16 also described a low bioavailability of the 52 
amyrin in mice, whereas diverse studies have shown that this compound is orally effective, which 53 
would not be in agreement with a poor bioavailability.11,17 Concerning other PT from the marigold, 54 
such as taraxasterol or faradiol, a lack of information on bioavalability has been found.  55 
One of the factors that might be related to these inconclusive results could be the variability on the 56 
composition of the digestion medium. In this respect, for most lipophilic compounds, it has been 57 
demonstrated that their bioaccessibility can be improved by the coexistence of other lipids in the 58 
intestinal tract.18 This is because the lipid digestion leads to the release of fatty acids and 59 
monoglycerides that enhance the formation of micellar structures with bile salts and phospholipids. 60 
These micelles will include other hydrophobic compounds present in the medium and in turn, the 61 
dispersion and absorption of the compounds vehiculized by these micellar structures. In fact, this is 62 
one of the fundamentals of current interest in the development of lipid-based delivery systems or 63 
the recent term “excipient foods” (a food that increases the bioavailability of bioactive agents that 64 
are co-ingested with it), for the improvement in the bioactivity of compounds for food and 65 
nutraceuticals.19,20 On the other hand, the association of bioactive compounds with lipid 66 
components has been suggested as a strategy with other advantages of interest, such as the 67 
protection of labile compounds against the conditions of the gastrointestinal tract.21,22 68 
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The aim of the present study was the production of a supercritical extract of Calendula officinalis, 69 
in absence and presence of co-solvent, and the characterization on their terpene composition. The 70 
subsequent in vitro gastrointestinal digestion of the extract was performed, both in absence and in 71 
co-existence with olive oil, in order to evaluate the bioaccessibility and the distribution of particle 72 
sizes of the digestion medium. Furthermore, the impact of the gastrointestinal digestion process on 73 
the antioxidant activity of the extract was also evaluated. 74 
 75 
MATERIALS AND METHODS 76 
Reagents and Materials 77 
Dry Calendula officinalis flowers were purchased from a local herbalist supplier (Murcia, Spain). 78 
The flowers were ground (particle size smaller than 500 µm) in a knife mill (Grindomix GM200 79 
RETSCH). Extra virgin olive oil was purchased from a local supermarket.  80 
Thymol, β-caryophillene, valencene, cedrol, β-sitosterol, tocopherol and alkane mixture (C7-C30) 81 
were from Sigma-Aldrich Chemie GmbH (Steinheim, Germany). The standard α-amyrin was from 82 
Extrasynthese (Genay, France).  83 
Trizma, maleic acid, Amano lipase A from Aspergillus niger, pepsin, pancreatin from porcine 84 
pancreas, bile salts, phosphatidyl choline from egg yolk and 2,2-diphenyl-1-picryl-hydrazyl (DPPH) 85 
were from Sigma-Aldrich Chemie GmbH (Steinheim, Germany).  86 
 87 
Supercritical extraction method 88 
Extractions were carried out in a pilot-scale supercritical fluid extractor (Thar Technology, 89 
Pittsburgh, PA, USA, model SF2000) comprising a 2 L cylindrical extraction cell and two different 90 
separators (S1 and S2), each of 0.5 L capacity, with control of temperature and pressure. The 91 
extraction cell was loaded with 400 g of the milled marigold and the CO2 flow rate was set to 70 92 
g/min. The extractions were carried out using pure CO2 or CO2 with ethanol as cosolvent (10% p/p). 93 
The extraction pressure and temperature were selected at 140 bar and 40 ºC and were kept constant 94 
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for all experimental assays. The separator conditions were 40 bar and 40 ºC. The total time 95 
extraction was 180 min. Samples were stored at -20 ºC until analysis.  96 
 97 
Analysis of terpene compounds of the extracts 98 
Samples were prepared at 15 mg/mL in chloroform:methanol (2:1, v/v) and were analyzed in an 99 
Agilent 7890A system (Agilent Technologies, Santa Clara, CA, USA) comprising a split/splitless 100 
injector, an electronic pressure control, a G4513A auto-injector and a 5975C triple-axis mass 101 
spectrometer detector. The column used was an Agilent HP-5MS capillary column (30 m × 0.25 102 
mm i.d., 0.25 µm phase thickness). Helium was used as carrier gas at 2 mL/min. The injector 103 
temperature was 260 °C and the mass spectrometer ion source and interface temperatures were 230 104 
and 280 °C, respectively. The sample injections (1 µL) were performed in splitless mode. The 105 
separation method of Crabas et al.8 was used with slight modifications. The oven temperature was 106 
initially at 60 °C and increased to 250 ºC at 4 ºC/min, followed by an increase to 310 °C at 3 107 
°C/min, and held for 5 min. The mass spectra were obtained by electronic impact at 70 eV. The 108 
scan rate was 1.6 scan/s at a mass range of 30-700 amu. Identification of compounds was performed 109 
by the NIST MS Data library, the retention indexes of the compounds, the mass spectra according 110 
to literature, or according to those of pure commercial compounds whenever possible. Quantitation 111 
of compounds was performed by calibration curves obtained from commercial standards whenever 112 
possible: thymol was used for monoterpenes, caryophillene and valencene were used for 113 
hydrogenated sesquiterpenes, cedrol was used for oxygenated sesquiterpenes, sitosterol was used 114 
for phytosterols, α-amyrin was used for PT, and tocopherol was quantitated by its own commercial 115 
standard. Other compounds such as alkanes were also quantitated by their own commercial 116 
compounds.      117 
 118 
In vitro gastrointestinal digestion 119 
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The in vitro digestion model was based on Martin, Moran-Valero, Vázquez, Reglero & Torres23 120 
with brief modifications and the inclusion of a gastric phase. For gastric digestion, 30 mg of 121 
marigold extract (ME) and 10 mg of lecithin were mixed with 14 mL of a gastric solution (150 mM 122 
NaCl, 6 mM CaCl2, pH 4.5). In case of the coexistence of dietary lipids, olive oil (OO) was added at 123 
a ratio of ME to oil of 1:2 (w/w). The mixture was placed in an orbital incubator at 200 rpm and 37 124 
ºC. After 2 min of agitation to allow the dispersion of the components, the gastric digestion was 125 
initiated by the addition of a fresh extract of gastric enzymes (170 mg of gastric lipase and 15 mg of 126 
pepsin in 3 mL of gastric solution and stirred for 10 min). Reaction was continued during 45 min.  127 
For intestinal digestion, a solution to simulate biliary secretion was prepared by mixing 0.1 g of 128 
lecithin, 0.25 g of bile salts, 0.5 mL of 325 mM CaCl2 solution, 1.5 mL of 3.25 mM NaCl solution, 129 
and 10 mL of Trizma-maleate buffer 100 mM pH 7.5. This mixture was homogenized for 1 min at 130 
3500 rpm (Ultra-Turrax IKA T18). Then, the biliary secretion was added to the gastric digestion 131 
and shaken in the orbital incubator for 2 min at 200 rpm and 37 ºC. The simulation of intestinal 132 
digestion was started by the addition of fresh pancreatin extract (0.5 g of pancreatin in 3 mL of 133 
Trizma-maleate buffer, stirred for 10 min and centrifuged at 1600 x g for 15 min). Reaction was 134 
continued during 60 min. The in vitro digestion of each sample was performed at least in triplicate. 135 
 136 
Determination of bioaccessibility 137 
At the end of digestion the medium was submitted to centrifugation at 4000 rpm for 40 min (5810R 138 
Eppendorf Iberica, Madrid, Spain). After centrifugation, an upper aqueous phase and a minor 139 
precipitated phase were obtained. The aqueous phase was filtered in order to isolate the aqueous 140 
solution containing the micellar structures (micellar phase, MP) from visible and non-solubilized 141 
particles of the ME. The components of the ME included in the MP were extracted and analyzed by 142 
GC-MS following the same procedure previously described. 143 
The bioaccessibility of each compound was determined as the fraction of each compound that was 144 
considered available for intestinal absorption, that is, included within the aqueous MP, as: 145 
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% bioaccessibility = (mg of compound in MP/mg of compound in digestion media) x 100 146 
 147 
Extraction of compounds from the digestion media 148 
At the end of digestion or after isolation of the MP, the components of the ME were extracted with 149 
hexane:methyl tert-butyl ether (50:50, v/v) at a ratio of 3:1 (v/v) of solvent to sample. The mixture 150 
was stirred for 1 min and centrifuged for 10 min at 4000 rpm (ScanSpeed mini, Micro Centrifuge). 151 
A second extraction was performed whith chloroform:methanol (2:1, v/v) at a ratio 3:1 (v/v) of 152 
solvent to sample. The two organic phases obtained were mixed and the solvent was removed by 153 
rotary evaporator. The obtained extract was solubilized in chloroform:methanol (2:1, v/v) at 15 154 
mg/mL and analyzed by GC-MS following the same procedure previously described. 155 
 156 
Particle size distribution after in vitro digestion 157 
The particles size distribution of the isolated MP from the in vitro digestion of ME in absence and 158 
presence of OO was measured. Furthermore, the particles size distribution was also determined for 159 
two control samples: 1) the MP isolated after in vitro digestion in absence of ME and in absence of 160 
OO, and 2) the MP isolated after in vitro digestion in absence of ME and in presence of OO. By this 161 
procedure, it was possible to determine the particles size distribution of the digestion medium itself, 162 
in order to distinguish the differences due to the presence of the experimental components.  163 
The particle size distributions were analyzed by mean of laser diffraction technique. A Mastersizer 164 
2000 instrument (Malvern Instruments Ltd., Malvern, Worcestershire, UK), equipped with a 165 
dispersion unit of solid particles in liquids (Hydro 2000MU) working at 2000 rpm, was used. 166 
Trizma-maleate buffer 100 mM pH 7.5 was used as dispersant. Assuming a volume distribution, the 167 
largest particle size D90 and the volume mean diameter D43 were the reported parameters. Analyses 168 
were performed in quintuplicate. 169 
 170 
Antioxidant activity of compounds by DPPH assay during in vitro digestion 171 
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The antioxidant activity of the digestion media was measured before in vitro digestion and after 172 
gastric and intestinal digestion by the DPPH test. The procedure of Martin, Moran-Valero, Casado, 173 
Reglero & Torres24 was used with brief modifications. The digestion medium was diluted in 174 
methanol:chloroform (5:1 v/v) up to 0.8 mg of ME/mL. An aliquot (500 µL) was added to 1500 µL 175 
of DPPH in methanol (0.06 mM). Samples were centrifuged at 12000 rpm for 5 min (miniSpin plus, 176 
Eppendorf). Then, reaction was completed after 60 min at room temperature and darkness, and 177 
absorbance was measured at 517 nm. Control experiments of the digestion medium in absence of 178 
the tested compounds (ME and OO) were also performed following the same procedure. The 179 
remaining DPPH concentration in the reaction medium was estimated by proper calibration curves 180 
of DPPH.   181 
Antioxidant activity was expressed as percentage of inhibition of DPPH as: 182 
% inhibition DPPH = 100 – [(µg DPPH/mLsample / µg DPPH/mLcontrol) x 100] 183 
 184 
Statistical analysis 185 
Statistical analyses were performed by means of the general linear model procedure of the SPSS 186 
17.0 statistical package (SPSS Inc., Chicago, IL, USA) by one-way analysis of variance. 187 
Differences were considered significant at p≤0.05. Post-hoc Tukey’s tests were performed in order 188 
to establish significant differences. Pearson’s correlation tests were used to study the 189 
bioaccessibility of compounds as related to their molecular properties. 190 
 191 
RESULTS AND DISCUSSION 192 
Characterization of supercritical extracts of Calendula officinalis 193 
The presence or absence of co-solvent in the supercritical extraction of Calendula officinalis led to 194 
some differences regarding yield and composition of the extract. The extraction yield of ME by CO2 195 
in absence of co-solvent was 2.1%, whereas that value was up to 7.5% in case of ethanol-CO2 196 
extraction. The identified compounds of both extracts are detailed in Table 1. More than 94% of the 197 
Page 9 of 35
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
 10
volatile compounds were identified for both extracts. According to the area percentage, the major 198 
abundance corresponded to alkanes (HC), followed by sesquiterpenes (S) and oxygenated 199 
triterpenes (OT), in case of extraction without co-solvent. In case of ethanol-CO2 extraction, a slight 200 
qualitative difference was found, mainly due to a lower proportion of HC and a higher proportion of 201 
OT. However, the major difference due to co-solvent was that the chromatographic areas for all the 202 
compounds were lower than the CO2 extraction without co-solvent (Table 1). Taking into account 203 
the higher yield of the ethanol-CO2 extraction, this result would suggest that the detected 204 
compounds could be diluted with other extracted compounds but non-detected by GC-MS under the 205 
used conditions.  206 
In any case, the general composition of both ME was in agreement with previous similar studies 207 
about supercritical extracts from this plant. Thus, α-cadinol, τ-cadinol, ɣ-cadinene and δ-cadinene 208 
are typical volatile compounds described for marigold.8,10,25 Furthermore, in the current study, the 209 
main detected PT were taraxasterol, lupeol, α-amyrin and β-amyrin, as well as diverse non-210 
identified sterols. The identification of PT from supercritical extracts of marigold has not been 211 
usually described in most previous studies, but most of them were focused on the typical terpenes of 212 
the essential oil of the extracts. 213 
It is important to remark that the relative abundances of the compounds in Table 1 cannot be 214 
considered to determine the major compounds of the extracts, due to their differences on 215 
chromatographic responses. Therefore, taking into account the importance of characterizing the 216 
extract due to its bioactive compounds of interest, especially PT, a proper quantitation as possible 217 
was performed for some of the compounds with the available commercial standards. As shown in 218 
Table 2, in absence of co-solvent, close to 15% of the chemical composition of the extract was 219 
quantitated, being the OT the most abundant family of compounds. In the specific case of bioactive 220 
PT (taraxasterol, lupeol, α-amyrin and β-amyrin), these compounds were close to 3% of the extract. 221 
Furthermore, up to 5% of the extract was also quantitated as non-identified sterols.    222 
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Regarding the ethanol-CO2 extract, due to the dilution effect with other extracted but non-identified 223 
compounds, the total amount of quantitated compounds by GC-MS was lower than 5%, but 224 
similarly to the CO2 extract, the major compounds were the OT (4%) and the bioactive PT were 225 
around 1.5% (Table 2).  226 
As summary, both supercritical ME might be considered of interest due to their content on bioactive 227 
PT, although the extraction of marigold in absence of co-solvent resulted in the preferred procedure. 228 
Therefore, taking into account the interest of the bioactive PT, the following studies were performed 229 
with the ME produced in absence of co-solvent. 230 
 231 
Bioaccessibility of supercritical extract of Calendula officinalis 232 
After in vitro digestion of the ME, the bioaccessibility of the major quantitated compounds of the 233 
extract was determined. Due to the complex composition of the extract, as well as the increased 234 
complexity of the chromatographic analyses due to the co-elution of other compounds from the 235 
digestion medium itself, a selection of compounds for the study of bioaccessibility was performed. 236 
Such selection was based on the preferential characterization of the bioactive compounds of interest 237 
(PT), as well as the consideration of other representative compounds of each chemical family of the 238 
extract (SH, OS and HC) that were present in the extract at concentration ≥ 0.1% at least. The 239 
selected compounds and their values of bioaccessibility are shown in Table 3. 240 
According to Table 3, the bioaccessible fraction of the compounds was quite variable, since 241 
percentages higher than 80% were found for some compounds, whereas other compounds showed 242 
values lower than 50%. In general, it seemed that the bioaccessibility of the family of compounds 243 
decreased in the following order: SH (84%) > OS (81%) > OT (77%) > HC (42%). Thus, it could be 244 
considered that most terpenes, included the PT, showed a high bioaccessibility, since more than 245 
75% of the amount of terpenes were found within the bioaccessible MP, including the bioactive PT 246 
(Table 3). The available information about the bioaccessibility of terpenes in general is scarce, and 247 
bioaccessibility values of PT in particular has not been found in the scientific literature, whereas 248 
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contradictory results have been reported about the bioavalability of compounds such as lupeol or 249 
amyrins.11, 13–17 According to the obtained results, the present study showed that the studied PT of a 250 
supercritical extract of ME might have high bioaccessibility.    251 
Diverse reasons might be considered to explain the observed results. In general, the bioaccessibility 252 
of compounds in the aqueous medium of the intestinal lumen is determined by their solubility. 26,27  253 
This solubility is not a problem for those compounds with a good hydrosolubility or 254 
hydrophilic/lipophilic balance that ensure its dispersion in the medium, either directly, or indirectly, 255 
by inclusion in vesicles, emulsion droplets, lamellar or micellar structures of bile salts and 256 
phospholipids naturally present in the intestinal tract.  In fact, absorption of lipophilic products 257 
takes place supported by these structures of the MP, which enhances the transport of such products 258 
to enterocytes through the unstirred water layer close to the microvillous membrane, where they are 259 
absorbed.26,27 According to this theory, most of terpenes might show a proper dispersion in the 260 
aqueous media after in vitro digestion. On the contrary, alkanes might not be so effectively 261 
dispersed within the medium and hence their lower bioaccessibility.  262 
In order to understand whether the obtained results were related to the lipophilicity of the 263 
compounds, the logP value of each individual substance listed in Figure 1 was considered (Food 264 
Database FooDB, www.foodb.ca). As it is illustrated in Figure 1, a negative correlation was found 265 
between the logP value of the compounds and their bioaccessibility (r = -0.771, P < 0.001). 266 
Therefore, the higher lipophilicity of the compounds, the worse the bioaccessibility is. Thus, logP 267 
values lower than 8 might be preferred for a high bioaccessibility (closer to 80%). All PT identified 268 
in ME showed logP values around 6.    269 
Another molecular property that has been popularly related to the bioavailability of drugs is the 270 
molecular flexibility, due to the number of rotatable bonds (NRB) described by Veber, Johnson, 271 
Cheng, Smith, Ward & Kopple28. A low NRB value has been suggested as one strong criterion for 272 
drug candidates with proper bioavailability, although the exact reason for such relation has not been 273 
established. According to Figure 2, a strong negative correlation was found between the NRB value 274 
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of the studied compounds (Molinspiration Cheminformatics, Bratislava, Slovak Republic) and their 275 
bioaccessibility (r = -0.860, P < 0.001). Therefore, the higher the molecular flexibility, the worse 276 
the bioaccessibility is. Thus, NRB values of 0 or 1 might be desirable for a high bioaccessibility of 277 
the studied compounds. This was considered an interesting result, since previous information on the 278 
relation between the molecular flexibility and bioaccessibility of compounds has not been 279 
described, but only the relation of NRB with bioavailability.  280 
Therefore, according to the obtained results, the compounds of bioactive interest of the ME showed 281 
high bioaccessibilities that might be related to their favorable molecular properties. At any case, 282 
further studies at this respect would be necessary in order to understand whether such proper 283 
bioaccessibility might lead to a positive bioavailability and bioactivity.  284 
 285 
Bioaccessibility of Calendula officinalis supercritical extract co-digested with olive oil 286 
Despite that the studied compounds showed a proper bioaccessibility, it was considered interesting 287 
the study of the role of the coexistence of lipids (olive oil, OO) during the digestion process in order 288 
to evaluate whether it would be possible to reach a complete bioaccessibility of the bioactive 289 
compounds of interest. Preliminary studies were performed in order to find the best ratio ME to oil 290 
that allowed the best bioaccessibility for most compounds (data not shown). This ratio was 291 
established as 1:2 (w/w) and the corresponding results are shown in Figure 3. In general, a higher 292 
bioaccessibility due to the OO factor was found (P<0.001). The different chemical families 293 
increased around 20% their bioaccessibility, and most compounds of interest reached values of 294 
bioaccessibility closer to 100%.  295 
During lipid digestion, the major hydrolysis products as fatty acids and monoglycerides are 296 
released. These compounds lead to the formation of micellar structures with bile salts and 297 
phospholipids, which is necessary for the proper absorption of fats by enterocytes. 27 This increase 298 
in the micellar surface compared to the absence of oil increases the available structures for inclusion 299 
of other hydrophobic compounds present in the aqueous media and hence, their bioaccessibility is 300 
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enhanced.18-20 This mechanism would be related to the results obtained in the present study. 301 
Therefore, the current study showed that despite the bioaccessibility of bioactive compounds such 302 
as PT from a supercritical extract of marigold was high; the co-digestion with particularly low 303 
levels of a typical dietary fat would be enough to reach a complete bioaccessibility of such 304 
compounds. In this respect, according to the term of “excipient food” recently described by 305 
McClements et al.,19 as a food that increases the bioavailability of bioactive agents that are co-306 
ingested with it, olive oil might be a potential candidate as “excipient food” to enhance the 307 
bioaccessibility of compounds of ME in general, and of bioactive PT in particular. As far as we 308 
know, previous studies about the effect of coexistence of oils on the gastrointestinal digestion 309 
behavior and bioaccessibility of PT have not been described in the scientific literature.  310 
 311 
Particle size distribution after in vitro digestion 312 
The particle size distribution of the isolated MP was characterized in order to deepen the 313 
understanding of the hypothesis that a better bioaccessibility of the compounds was due to an 314 
enhanced dispersion by digested lipids. Previously, we considered necessary to understand the 315 
typical particles size distribution of the own MP in absence of any of the experimental compounds, 316 
that is, in absence of ME and OO. As shown in Figure 4.a, there were two major peaks, one in the 317 
range of 0.2 µm, and a second one in the range of 1 µm. Furthermore, another abundant volume of 318 
particles was found within a wide range of sizes between 4 and 240 µm. This distribution led to a 319 
MP characterized by particles most of them lower than 25 µm (D90) and a volume mean diameter 320 
around 11 µm (D43). It is complicated to determine the precise components of the medium 321 
responsible of such distribution, but it might probably be related to the particles formed by 322 
phospholipids, bile salts, either individually or in combination as micelles or vesicles.29 323 
When OO was digested, the particle size distribution of the MP changed (Figure 4.b). The typical 324 
modes at 0.2 and 1 µm were also present, but the area of the mode at 0.2 µm was higher, whereas 325 
the modes at 1 and 4-240 µm were much lower. Thus, the MP was characterized by particles most 326 
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of them lower than 2 µm (D90) and a volume mean diameter around 7 µm (D43). The obtained 327 
results would suggest that the hydrolysis products of OO, mainly fatty acids and monoglycerides, 328 
contributed to an increase in the number of particles of lower size within the MP. These observed 329 
results were quite useful since they could confirm that the in vitro digestion model led to a 330 
physiological and favorable situation to enhance the dispersion of other lipophilic compounds in the 331 
aqueous media.  332 
When the ME was digested in absence of OO, the typical modes of the medium at 0.2 and 1 µm 333 
were present again; however, a relevant decrease was produced at the expense of an increase in the 334 
abundance of bigger particles (Figure 4.c). In fact, three new modes of particles appeared in the 335 
range of 6 µm, 65 µm and 500 µm. Thus, in presence of ME, the MP was characterized by bigger 336 
particles, because the 10% of particles were even higher than 190 µm (D90) and the volume mean 337 
diameter was around 47 µm (D43). This distribution was quite different compared to the control 338 
samples (Figure 4.a and 4.b). Therefore, it could be thought that the obtained results might be 339 
mainly related to particles of the ME dispersed in the aqueous media, either in isolation or by 340 
interacting with components of the medium.  341 
When the ME was digested in co-existence with OO, the basic modes of the medium at 0.2 and 1 342 
µm increased again and the big particle sizes previously observed for the ME sample decreased at 343 
the expense of the formation of a wide mode in the range of 15-200 µm (Figure 4.d). Thus, in 344 
presence of OO, the MP from the digestion of ME was characterized by lower particles than in 345 
absence of OO, being most of them lower than 28 µm (D90) and a volume mean diameter around 9 346 
µm (D43). Those values were closer to those obtained for the control sample of MP in absence of 347 
ME and OO (Figure 4.a). This might confirm our proposed theory that hydrolysis products of lipids 348 
could enhance the dispersion of hydrophobic compounds of ME, by increasing the number of lower 349 
size particles.                          350 
Therefore, the study of the distribution of particle sizes after in vitro digestion of ME showed that 351 
the co-digestion of the extract with low levels of a typical dietary fat might enhance the dispersion 352 
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of the marigold components within the aqueous phase of the intestinal medium and, in turn, would 353 
enhance its bioaccessibility (Table 3). As far to our knowledge, previous studies on the particle size 354 
distribution of the aqueous medium after digestion of ME, either with or without oils, have not been 355 
described in the scientific literature. In any case, further studies would be necessary in order to 356 
confirm the observed evidences, taking into account that the diluting and stirring conditions 357 
commonly used for particle size measurement might lead to the formation of artefacts.  358 
 359 
Antioxidant activity of Calendula officinalis supercritical extract during in vitro digestion  360 
The modification of the antioxidant activity of diverse compounds, either negatively or positively, 361 
after the process and conditions of gastrointestinal digestion has been previously described. In case 362 
of a detrimental effect after digestion, the association of bioactive compounds with lipid 363 
components has been reported as a strategy to protect those labile compounds from the conditions 364 
of the gastrointestinal tract.21,22 Therefore, taking into account that some components of marigold 365 
have been described as antioxidants, it was considered interesting the study of the impact of the 366 
digestion process on such activity, either in absence or in presence of olive oil. 367 
As shown in Figure 5, the ability of the ME to inhibit the DPPH radical significantly increased with 368 
the course of the gastrointestinal digestion (P=0.006). Such increase was especially significant after 369 
intestinal digestion for both treatments. Furthermore, the final inhibitory activity that was observed 370 
after intestinal digestion was quite similar between treatments, regardless of the presence or absence 371 
of OO. Thus, the inhibitory activity of ME increased after gastrointestinal digestion around 50% 372 
and 40% for the treatments in absence and presence of OO, respectively. The improvement of the 373 
antioxidant activity of compounds during the gastrointestinal process has been previously described, 374 
especially for polyphenols, due to their release during the hydrolysis processes from other complex 375 
molecules.30 As far as we know, previous information about the antioxidant activity of compounds 376 
from ME as affected by gastrointestinal digestion has not been described.   377 
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Therefore, the observed results showed that the antioxidant effect of ME was not negatively 378 
affected, but rather enhanced by the in vitro gastrointestinal process. Additionally, it seemed that 379 
the better dispersion of the extract that was found in presence of OO was not related to these results, 380 
at least in the case of intestinal digestion, since during gastric digestion the antioxidant activity was 381 
significantly higher in presence of OO. Other in vitro and in vivo studies would be necessary in 382 
order to evaluate whether these preliminary results would be related to enhanced antioxidant 383 
activities of a digested ME. 384 
As a summary, the present study showed that supercritical extraction in absence of co-solvent is the 385 
preferred procedure for producing a marigold extract rich in bioactive compounds such as 386 
pentacyclic triterpenes. Although that such bioactive compounds show a good bioaccessibility, it 387 
can be even improved by the co-digestion with particularly low levels of a typical dietary fat such 388 
as olive oil, thanks to a better dispersion of the extract in the aqueous media during gastrointestinal 389 
digestion. Additionally, the gastrointestinal process enhances the antioxidant activity of the extract, 390 
regardless of the co-digestion with olive oil. The obtained results are of interest either to obtaining a 391 
deeper knowledge on the potential of the marigold plant as a possible bioactive ingredient of foods, 392 
as well as to contributing to the general knowledge on the gastrointestinal digestion of bioactive 393 
compounds such as pentacyclic triterpenes, together with other typical compounds of supercritical 394 
extracts of plants in general, such as sesquiterpenes or alkanes.  395 
 396 
ABBREVIATIONS USED 397 
ME Marigold extract 
PT Pentacyclic triterpenes 
OO Olive oil  
SFE Supercritical fluid extraction 
MP Micellar phase 
HC Alkanes 
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S Sesquiterpenes 
SH Sesquiterpenes hydrocarbons 
OT Oxygenated triterpenes 
OS Oxygenated sesquiterpenes 
NRB Number of rotatable bonds 
 398 
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Figure Captions 496 
 497 
Figure 1. Correlation between lipophilicity (logP) of compounds from supercritical marigold 498 
extract and their bioaccessibility (%) 499 
 500 
Figure 2. Correlation between molecular flexibility (NRB) of compounds from supercritical 501 
marigold extract and their bioaccessibility (%) 502 
 503 
Figure 3. Bioaccessibility (%) of compounds from supercritical marigold extract as affected by 504 
olive oil during in vitro digestion. Bars within the same compound are significantly different if p ≤ 505 
0.05 (*), p ≤ 0.01 (**) or p ≤ 0.001 (***). 506 
 507 
Figure 4. Volume particle size distribution of the digestion media after in vitro digestion. Isolated 508 
aqueous micellar phase after in vitro digestion of a) without marigold and without olive oil, b) 509 
without marigold and with olive oil, c) with marigold and without olive oil, and d) with marigold 510 
and with olive oil.    511 
 512 
Figure 5. Evolution of the antioxidant activity of supercritical marigold extract throughout in vitro 513 
digestion. Different letters within the same treatment are significantly different. Bars within the same color 514 
are significantly higher if p ≤ 0.05 (*) or p ≤ 0.001 (***). 515 
 516 
 517 
 518 
 519 
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Table 1. GC-MS Characterization of Supercritical Extracts of Calendula Officinalis 
RI Compound CO2 Ethanol-CO2 
  Area % Area % 
1295 Thymol 1535567 0.74 414731 0.91 
1304 Carvacrol 613051 0.30 185772 0.41 
1351 α-Cubebene 416655 0.20 105666 0.23 
1378 α-Copaene 968862 0.47 272124 0.60 
1391 β-Cubebene  625195 0.30 113123 0.25 
1430 β-Gurjunene 481604 0.23 69838 0.15 
1442 β-Humulene 95765 0.05 96099 0.21 
1464 Alloaromadendrene 898623 0.43 163108 0.36 
1478 ɣ-Muurolene 901727 0.43 248135 0.55 
1487 β-Ionone 617759 0.30 119421 0.26 
1490 β-Selinene 363937 0.18 33297 0.07 
1497 (+)-Ledene 2385902 1.15 495858 1.09 
1502 α-Muurolene 1756737 0.85 464359 1.02 
1516 ɣ-Cadinene 5778816 2.78 2006429 4.42 
1525 δ-Cadinene 6024229 2.90 1726232 3.80 
1528 Dihydroactinidiolide 2694113 1.30 795656 1.75 
1535 Cadina-1(2),4-diene 1330919 0.64 115862 0.25 
1539 α-Cadinene 1086998 0.52 249607 0.55 
1544 α-Calacorene 408864 0.20 61864 0.14 
1593 Viridifloror 3118592 1.50 389411 0.86 
1610 1-10-di-epi-cubenol 805223 0.39 212891 0.47 
1616 δ-Cadinol 749509 0.36 151504 0.33 
1629 Cubenol 824483 0.40 190310 0.42 
1645 τ-Cadinol 10030609 4.83 2369705 5.22 
1648 n.i. oxygenated sesquiterpene 1062037 0.51 264170 0.58 
1652 β-Eudesmol 2101899 1.01 430441 0.95 
1658 α-Cadinol 12114169 5.83 2456127 5.41 
1670 n.i. a 1095520 0.53 218458 0.48 
1711 3-Hydroxy-5,6-epoxy-β-ionone 1793930 0.86 n.d. b n.d. 
1740 1-cyclohexanone, 2-methyl-2-(3-
methyl-2-oxobutyl) 
10426982 5.02 2808684 6.18 
1779 9,10- 16481274 7.93 5541526 12.20 
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dimethyltricyclo[4.2.1.1.(2,5)]decane-
9,10-diol 
1840 n.i. 857747 0.41 n.d. n.d. 
1846 Hexahydrofarnesyl acetone 4377593 2.11 n.d. n.d. 
1901 Nonadecane 4110435 1.98 862927 1.90 
1970 Verticiol 2312239 1.11 547645 1.21 
1996 Palmitic acid, ethyl ester 315697 0.15 111172 0.24 
2001 Eicosane 980904 0.47 163966 0.36 
2101 Heneicosane 6802339 3.27 1116421 2.46 
2201 Docosane 630054 0.30 104863 0.23 
2302 Tricosane 8930569 4.30 1385382 3.05 
2402 Tetracosane 1111476 0.54 148787 0.33 
2503 Pentacosane 13651831 6.57 1894387 4.17 
2601 Hexacosane 980678 0.47 89782 0.20 
2708 Heptacosane 18232039 8.78 1943518 4.28 
2797 Octacosane 2050351 0.99 242332 0.53 
2892 Nonacosane 19427953 9.35 2277964 5.01 
2978 Triacontane 2191196 1.05 n.d. n.d. 
- Hentriacontane 11165954 5.38 1739227 3.83 
- α-Tocopherol 827910 0.40 442105 0.97 
- Dotriacontane 180722 0.09 n.d. n.d. 
- n.i. sterol 175177 0.08 n.d. n.d. 
- n.i. sterol 728069 0.35 540417 1.19 
- n.i. sterol 2017797 0.97 710705 1.56 
- β-Amyrenone 578061 0.28 262928 0.58 
- β-Amyrin 2940308 1.42 1433928 3.16 
- n.i. sterol 595111 0.29 287959 0.63 
- α-Amyrin + Lupeol 4327976 2.08 2095993 4.61 
- n.i. oxygenated triterpene 643359 0.31 226066 0.50 
- Taraxasterol 6422306 3.09 3910398 8.61 
- n.i. 565285 0.27 128466 0.28 
      
 Oxygenated monoterpenes  2.3  3.1 
 Sesquiterpenes hydrocarbons  11.6  14.0 
 Oxygenated sesquiterpenes  14.3  13.7 
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 Oxygenated diterpenes  1.1  1.2 
 Oxygenated triterpenes  7.3  17.9 
 Alkanes  43.5  26.3 
 Other compounds  16.1  18.6 
 Total identified compounds  96.3  94.8 
a n.i. = non identified; b n.d. = non detected 
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Table 2. Quantitative Composition (mg/g) of Supercritical Extract of Calendula Officinalis 
Compound CO2 Ethanol-CO2 
Thymol 0.60 0.16 
Carvacrol 0.24 0.07 
α-Cubebene 0.18 0.05 
α-Copaene 0.42 0.12 
β-Cubebene  0.27 0.05 
β-Gurjunene 0.21 0.03 
β-Humulene 0.04 0.04 
Alloaromadendrene 0.39 0.07 
ɣ-Muurolene 0.39 0.11 
β-Selinene 0.18 0.02 
(+)-Ledene 1.19 0.25 
α-Muurolene 0.88 0.23 
ɣ-Cadinene 2.89 1.00 
δ-Cadinene 3.02 0.86 
Cadina-1(2),4-diene 0.67 0.06 
α-Cadinene 0.54 0.13 
α-Calacorene 0.20 0.03 
Viridifloror 1.11 0.14 
1-10-di-epi-cubenol 0.29 0.08 
δ-Cadinol 0.27 0.05 
Cubenol 0.29 0.07 
τ-Cadinol 3.56 0.84 
n.i. a Oxygenated sesquiterpene 0.38 0.09 
β-Eudesmol 0.75 0.15 
α-Cadinol 4.30 0.87 
Nonadecane 1.02 0.21 
Eicosane 0.25 0.04 
Heneicosane 1.81 0.30 
Docosane 0.18 0.03 
Tricosane 2.62 0.41 
Tetracosane 0.34 0.05 
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Pentacosane 4.64 0.64 
Hexacosane 0.38 0.03 
Heptacosane 8.55 0.91 
Octacosane 1.19 0.14 
Nonacosane 14.27 1.67 
Triacontane 2.13 n.d. b 
Hentriacontane 10.83 1.69 
α-Tocopherol 1.29 0.69 
Dotriacontane 0.18 n.d. 
n.i. sterol 2.65 n.d. 
n.i. sterol 11.00 8.16 
n.i. sterol 30.48 10.74 
β-Amyrenone 1.20 0.54 
β-Amyrin 6.08 2.97 
n.i. sterol 8.99 4.35 
α-Amyrin + Lupeol 8.96 4.34 
n.i. oxygenated triterpene 1.33 0.47 
Taraxasterol 13.29 8.09 
   
Oxygenated monoterpenes 0.8 0.2 
Sesquiterpenes hydrocarbons 11.5 3.1 
Oxygenated sesquiterpenes 10.9 2.3 
Oxygenated triterpenes 85.5 40.4 
Alkanes 48.6 6.1 
Total quantitated compounds 156.9 52.1 
a n.i. = non identified; b n.d. = non detected 
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Table 3. Bioaccessibility (%) of Supercritical Extract of Calendula Officinalis 
Compound Chemical group a Bioaccessibility 
ɣ-Cadinene SH 79.3 ± 9.7 
δ-Cadinene SH 87.9 ± 11.8 
τ-Cadinol OS 75.1 ± 3.4 
ɑ-Cadinol OS 87.1 ± 3.7 
Nonadecane HC 48.1 ± 2.0 
Tricosane HC 57.2 ± 11.0 
Pentacosane HC 48.3 ± 2.8 
Heptacosane HC 13.8 ± 2.4 
α-Tocopherol OT 71.1 ± 6.5 
β-Amyrin OT 79.8 ± 4.8 
α-Amyrin + Lupeol OT 82.1 ± 8.8 
Taraxasterol OT 75.5 ± 2.1 
   
Sesquiterpenes hydrocarbons  83.6 ± 10.8 
Oxygenated sesquiterpenes  81.1 ± 3.6 
Oxygenated triterpenes  77.1 ± 2.9 
Alkanes  41.8 ± 3.5 
a SH = sesquiterpene hydrocarbon, OS = oxygenated sesquiterpene, HC = alkanes, OT = oxygenated triterpene 
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Figure 1.  
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Figure 2.  
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Figure 3.  
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Bars within the same compound are significantly different if p ≤ 0.05 (*), p ≤ 0.01 (**) or p ≤ 0.001 (***). 
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Figure 4.  
a) b) 
0
1
2
3
4
5
6
7
0.01 0.10 1.00 10.00 100.00 1000.00
V
o
lu
m
e
 %
Particle size (µm)  
0
1
2
3
4
5
6
7
0.01 0.10 1.00 10.00 100.00 1000.00
V
o
lu
m
e
 %
Particle size (µm)  
c) d) 
0
1
2
3
4
5
6
7
0.01 0.10 1.00 10.00 100.00 1000.00
V
o
lu
m
e
 %
Particle size (µm)  
0
1
2
3
4
5
6
7
0.01 0.10 1.00 10.00 100.00 1000.00
V
o
lu
m
e
 %
Particle size (µm)  
Isolated aqueous micellar phase after in vitro digestion of a) without marigold and without olive oil, b) without marigold 
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Figure 5.  
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Different letters within the same treatment are significantly different. Bars within the same color are significantly 
higher if p ≤ 0.05 (*) or p ≤ 0.001 (***).  
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